Abstract
Local treatment improves outcome of RAI - Refractory differentiated thyroid carcinoma (DTC) patients irrespectively of tyrosine kinase inhibitors (TKI) treatment: a single center experience
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
